The impact of intravitreal therapy of diabetic macular edema on the local and systemic production of cytokines

Purpose: to analyze the levels of cytokines in intraocular fluid (IF) and blood plasma of patients with diabetic macular edema (DME) previously untreated by intravitreal therapy before and after the therapy by angiogenesis inhibitor or a corticosteroid. Material and methods. We examined 90 people —...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Zh. Fursova, A. S. Derbeneva, O. S. Kozhevnikova, D. V. Telegina, V. A. Devyatkin
Format: Article
Language:Russian
Published: Real Time Ltd 2023-03-01
Series:Российский офтальмологический журнал
Subjects:
Online Access:https://roj.igb.ru/jour/article/view/1180
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849396005673369600
author A. Zh. Fursova
A. S. Derbeneva
O. S. Kozhevnikova
D. V. Telegina
V. A. Devyatkin
author_facet A. Zh. Fursova
A. S. Derbeneva
O. S. Kozhevnikova
D. V. Telegina
V. A. Devyatkin
author_sort A. Zh. Fursova
collection DOAJ
description Purpose: to analyze the levels of cytokines in intraocular fluid (IF) and blood plasma of patients with diabetic macular edema (DME) previously untreated by intravitreal therapy before and after the therapy by angiogenesis inhibitor or a corticosteroid. Material and methods. We examined 90 people — 47 females (52.2 %) and 43 males (47.8 %), mean age 64.54 ± 11.30 years. Of these, 60 had DME, and 30 formed the control group. The levels of 41 cytokines/chemokines in IF were determined by Milliplex® Map Human Cytokine/ Chemokine Panel; while the concentration of IL-18, MCP-1/CCL2, EPO, IL-10, IL-4, IL-6, IL-8, IFNα, VEGF-A in blood plasma was measured by enzyme-linked immunosorbent assay kits (Vector-Best, Russia). Patients with DME received intravitreal injections of an angiogenesis inhibitor (aflibercept. 50 eyes) or a corticosteroid (dexamethasone implant, 30 eyes). Results. Significant differences were revealed in 10 cytokine concentrations between the DME patients and the control group. The concentrations of IL-7, IL-15 and MCP-1/CCL2 levels in IF of DME patients were, respectively, 20.5, 20.3, and 11.02 times higher, than in the control group (р ˂ 0.05). Besides, a pairwise comparison of cytokines concentrations in IF of patients from either treatment group with the controls demonstrated a statistically significant increase in GROα/CXCL1 level. The pairwise comparison also revealed significant differences between the control and the corticosteroid therapy for systemic concentrations of IL-18 (p = 0.017), MCP-1/CCL2 (p = 0.009) and VEGF-A (p = 0.016). Conclusion. A pronounced and significant increase of the levels of a number of cytokines (e.g., IL-7, IL-15. FRACTALKINE/CX3CL1) were only sparsely reported before or remained undetermined at all. Our results on systemic cytokines levels may serve as prerequisite for further research into the role of systemic inflammation in DME pathogenesis. The analysis of associations of our results with those of other clinical biomarkers will contribute to the development of individualized treatment strategies.
format Article
id doaj-art-8113d3ccf40b42ec9b71f4d361267edc
institution Kabale University
issn 2072-0076
2587-5760
language Russian
publishDate 2023-03-01
publisher Real Time Ltd
record_format Article
series Российский офтальмологический журнал
spelling doaj-art-8113d3ccf40b42ec9b71f4d361267edc2025-08-20T03:39:28ZrusReal Time LtdРоссийский офтальмологический журнал2072-00762587-57602023-03-0116112713410.21516/2072-0076-2023-16-1-127-134560The impact of intravitreal therapy of diabetic macular edema on the local and systemic production of cytokinesA. Zh. Fursova0A. S. Derbeneva1O. S. Kozhevnikova2D. V. Telegina3V. A. Devyatkin4Novosibirsk State Regional Hospital; Novosibirsk State Medical UniversityNovosibirsk State Regional Hospital; Novosibirsk State Medical UniversityFederal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of SciencesFederal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of SciencesFederal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of SciencesPurpose: to analyze the levels of cytokines in intraocular fluid (IF) and blood plasma of patients with diabetic macular edema (DME) previously untreated by intravitreal therapy before and after the therapy by angiogenesis inhibitor or a corticosteroid. Material and methods. We examined 90 people — 47 females (52.2 %) and 43 males (47.8 %), mean age 64.54 ± 11.30 years. Of these, 60 had DME, and 30 formed the control group. The levels of 41 cytokines/chemokines in IF were determined by Milliplex® Map Human Cytokine/ Chemokine Panel; while the concentration of IL-18, MCP-1/CCL2, EPO, IL-10, IL-4, IL-6, IL-8, IFNα, VEGF-A in blood plasma was measured by enzyme-linked immunosorbent assay kits (Vector-Best, Russia). Patients with DME received intravitreal injections of an angiogenesis inhibitor (aflibercept. 50 eyes) or a corticosteroid (dexamethasone implant, 30 eyes). Results. Significant differences were revealed in 10 cytokine concentrations between the DME patients and the control group. The concentrations of IL-7, IL-15 and MCP-1/CCL2 levels in IF of DME patients were, respectively, 20.5, 20.3, and 11.02 times higher, than in the control group (р ˂ 0.05). Besides, a pairwise comparison of cytokines concentrations in IF of patients from either treatment group with the controls demonstrated a statistically significant increase in GROα/CXCL1 level. The pairwise comparison also revealed significant differences between the control and the corticosteroid therapy for systemic concentrations of IL-18 (p = 0.017), MCP-1/CCL2 (p = 0.009) and VEGF-A (p = 0.016). Conclusion. A pronounced and significant increase of the levels of a number of cytokines (e.g., IL-7, IL-15. FRACTALKINE/CX3CL1) were only sparsely reported before or remained undetermined at all. Our results on systemic cytokines levels may serve as prerequisite for further research into the role of systemic inflammation in DME pathogenesis. The analysis of associations of our results with those of other clinical biomarkers will contribute to the development of individualized treatment strategies.https://roj.igb.ru/jour/article/view/1180diabetic macular edemacytokinesintraocular fluidanti-angiogenic treatment
spellingShingle A. Zh. Fursova
A. S. Derbeneva
O. S. Kozhevnikova
D. V. Telegina
V. A. Devyatkin
The impact of intravitreal therapy of diabetic macular edema on the local and systemic production of cytokines
Российский офтальмологический журнал
diabetic macular edema
cytokines
intraocular fluid
anti-angiogenic treatment
title The impact of intravitreal therapy of diabetic macular edema on the local and systemic production of cytokines
title_full The impact of intravitreal therapy of diabetic macular edema on the local and systemic production of cytokines
title_fullStr The impact of intravitreal therapy of diabetic macular edema on the local and systemic production of cytokines
title_full_unstemmed The impact of intravitreal therapy of diabetic macular edema on the local and systemic production of cytokines
title_short The impact of intravitreal therapy of diabetic macular edema on the local and systemic production of cytokines
title_sort impact of intravitreal therapy of diabetic macular edema on the local and systemic production of cytokines
topic diabetic macular edema
cytokines
intraocular fluid
anti-angiogenic treatment
url https://roj.igb.ru/jour/article/view/1180
work_keys_str_mv AT azhfursova theimpactofintravitrealtherapyofdiabeticmacularedemaonthelocalandsystemicproductionofcytokines
AT asderbeneva theimpactofintravitrealtherapyofdiabeticmacularedemaonthelocalandsystemicproductionofcytokines
AT oskozhevnikova theimpactofintravitrealtherapyofdiabeticmacularedemaonthelocalandsystemicproductionofcytokines
AT dvtelegina theimpactofintravitrealtherapyofdiabeticmacularedemaonthelocalandsystemicproductionofcytokines
AT vadevyatkin theimpactofintravitrealtherapyofdiabeticmacularedemaonthelocalandsystemicproductionofcytokines
AT azhfursova impactofintravitrealtherapyofdiabeticmacularedemaonthelocalandsystemicproductionofcytokines
AT asderbeneva impactofintravitrealtherapyofdiabeticmacularedemaonthelocalandsystemicproductionofcytokines
AT oskozhevnikova impactofintravitrealtherapyofdiabeticmacularedemaonthelocalandsystemicproductionofcytokines
AT dvtelegina impactofintravitrealtherapyofdiabeticmacularedemaonthelocalandsystemicproductionofcytokines
AT vadevyatkin impactofintravitrealtherapyofdiabeticmacularedemaonthelocalandsystemicproductionofcytokines